Next-Generation Sequencing Panel Analysis of Clinically Relevant Mutations in Circulating Cell-Free DNA from Patients with Gestational Trophoblastic Neoplasia: A Pilot Study.

MLA

Luo, Lingxiao, et al. “Next-Generation Sequencing Panel Analysis of Clinically Relevant Mutations in Circulating Cell-Free DNA from Patients with Gestational Trophoblastic Neoplasia: A Pilot Study.” BioMed Research International, Jan. 2020, pp. 1–11. EBSCOhost, https://doi.org/10.1155/2020/1314967.

APA

Luo, L., Lin, L., Zhang, X., Cai, Q., Zhao, H., Xu, C., & Cong, Q. (2020). Next-Generation Sequencing Panel Analysis of Clinically Relevant Mutations in Circulating Cell-Free DNA from Patients with Gestational Trophoblastic Neoplasia: A Pilot Study. BioMed Research International, 1–11. https://doi.org/10.1155/2020/1314967

Chicago

Luo, Lingxiao, Ling Lin, Xiaoyan Zhang, Qingqing Cai, Hongbo Zhao, Congjian Xu, and Qing Cong. 2020. “Next-Generation Sequencing Panel Analysis of Clinically Relevant Mutations in Circulating Cell-Free DNA from Patients with Gestational Trophoblastic Neoplasia: A Pilot Study.” BioMed Research International, January, 1–11. doi:10.1155/2020/1314967.